On Invalid Date, Zomedica (NYSEMKT: ZOM) reported Q3 2023 earnings per share (EPS) of -$0.00, up 80% year over year. Total Zomedica earnings for the quarter were -$266.00 thousand. In the same quarter last year, Zomedica's earnings per share (EPS) was -$0.01.
As of Q4 2023, Zomedica's earnings has grown year over year. Zomedica's earnings in the past year totalled -$14.50 million.
What was ZOM's revenue last quarter?
On Invalid Date, Zomedica (NYSEMKT: ZOM) reported Q3 2023 revenue of $6.35 million up 32.89% year over year. In the same quarter last year, Zomedica's revenue was $4.78 million.
What was ZOM's revenue growth in the past year?
As of Q4 2023, Zomedica's revenue has grown 42.44% year over year. This is 31.25 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 11.19%. Zomedica's revenue in the past year totalled $24.01 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.